Results

eNauka >  Rezultati >  Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Naziv: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Autori: Mistry, Pramod K.; Balwani, Manisha; Baris, Hagit N.; Turkia, Hadhami Ben; Burrow, T. Andrew; Charrow, Joel; Cox, Gerald F.; Danda, Sumita; Dragosky, Marta; Drelichman, Guillermo;
El-Beshlawy, Amal; Fraga, Cristina; Freisens, Selena; Gaemers, Sebastiaan; Hadjiev, Evgueniy; Kishnani, Priya S.; Lukina, Elena; Maison-Blanche, Pierre; Martins, Ana Maria; Pastores, Gregory; Petakov, Milan ; Peterschmitt, M. Judith; Rosenbaum, Hanna; Rosenbloom, Barry; Underhill, Lisa H.; Cox, Timothy M.;
Godina: 2018
Publikacija: Blood Cells, Molecules, and Diseases
ISSN: 1079-9796 Blood Cells Molecules and Diseases Pretraži identifikator
Izdavač: Orlando, FL : Academic Press
Tip rezultata: Naučni članak
Kolacija: vol. 71 str. 71-74
DOI: 10.1016/j.bcmd.2018.04.001
WoS-ID: 000432496500013
Scopus-ID: 2-s2.0-85046818875
PMID: 29680197
URI: https://enauka.gov.rs/handle/123456789/531584
Izvor metapodataka: Migrirano iz RIS podataka
M-kategorija: 
22M22 - Međunarodni časopis kategorije M22

27
SCOPUSTM
13
PubMed CentralTM
21
OpenCitations
23
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.